Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk

Science of the Total Environment

Volumn 409, Issue 9, 2011, Pages 1638-1642

  Chung, Chi Jung ^a   Lee, Hui Ling ^b,e   Yang, Hsiu Yuan ^a   Lin, Pinpin ^c   Pu, Yeong Shiau ^d   Shiue, Horng Sheng ^e   Su, Chien Tien ^f   Hsueh, Yu Mei ^a,g  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

4 (methylnitrosamino) 1 (3 pyridyl) 1 butanol; 4 (methylnitrosamino) 1 (3 pyridyl) 1 butanone; Cigarette smoking; NNAL; NNK; Urothelial carcinoma

Indexed keywords

1-BUTANOL; CIGARETTE SMOKING; NNAL; NNK; PYRIDYL; UROTHELIAL CARCINOMA;

ALCOHOLS; BIOMARKERS; BIOMOLECULES; BODY FLUIDS; KETONES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; MULTIVARIANT ANALYSIS; SURVEYS; TOBACCO;

RISK PERCEPTION;

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; GLUCURONIDE;

BIOMARKER; CANCER; HEALTH RISK; METABOLITE; RISK FACTOR; SMOKING;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NONPARAMETRIC TEST; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; TANDEM MASS SPECTROMETRY; TRANSITIONAL CELL CARCINOMA; URINALYSIS;

BIOLOGICAL MARKERS; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; GLUCURONIDES; HUMANS; MALE; MIDDLE AGED; NITROSAMINES; PYRIDINES; RISK FACTORS; SMOKING; UROLOGIC NEOPLASMS;

EID: 79952002991     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2011.01.046     Document Type: Article

References (26)

1. Anderson K.E., Carmella S.G., Ye M., Bliss R.L., Le C., Murphy L., et al. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. J Natl Cancer Inst 2001, 93:378-381.
2. Carmella S.G., Akerkar S.A., Richie J.P., Hecht S.S. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev 1995, 4:635-642.
3. Carmella S.G., Han S., Villalta P.W., Hecht S.S. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' blood. Cancer Epidemiol Biomarkers Prev 2005, 14:2669-2672.
4. Chung C.J., Huang C.J., Pu Y.S., Su C.T., Huang Y.K., Chen Y.T., et al. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area. Toxicol Appl Pharmacol 2008, 226:14-21.
5. Church T.R., Anderson K.E., Caporaso N.E., Geisser M.S., Le C.T., Zhang Y., et al. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev 2009, 18:260-266.
6. Derby K.S., Cuthrell K., Caberto C., Carmella S., Murphy S.E., Hecht S.S., et al. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer. Int J Cancer 2009, 125:2418-2424.
7. Etter J.F., Vu D.T., Perneger T.V. Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol 2000, 151:251-258.
8. Gallagher C.J., Muscat J.E., Hicks A.N., Zheng Y., Dyer A.M., Chase G.A., et al. The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer. Cancer Epidemiol Biomarkers Prev 2007, 16:823-828.
9. Goniewicz M.L., Havel C.M., Peng M.W., Jacob P., Dempsey D., Yu L., et al. Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer Epidemiol Biomarkers Prev 2009, 18:3421-3425.
10. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998, 11:559-603.
11. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999, 91:1194-1210.
12. Hecht S.S., Carmella S.G., Kenney P.M., Low S.H., Arakawa K., Yu M.C. Effects of cruciferous vegetable consumption on urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in singapore chinese. Cancer Epidemiol Biomarkers Prev 2004, 13:997-1004.
13. Johansson S.L., Cohen S.M. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 1997, 13:291-298.
14. Kavvadias D., Scherer G., Cheung F., Errington G., Shepperd J., McEwan M. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers. Biomarkers 2009, 14:547-553.
15. Lee H.L., Hsueh Y.M., Chung C.J., Pu Y.S., Chang L.W., Hsieh D.P., et al. Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients. Cancer Epidemiol Biomarkers Prev 2008, 17:3390-3395.
16. Muscat J.E., Djordjevic M.V., Colosimo S., Stellman S.D., Richie J.P. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer 2005, 103:1420-1426.
17. Pu Y.S., Yang S.M., Huang Y.K., Chung C.J., Huang S.K., Chiu A.W., et al. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol Appl Pharmacol 2007, 218:99-106.
18. Richie J.P., Carmella S.G., Muscat J.E., Scott D.G., Akerkar S.A., Hecht S.S. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev 1997, 6:783-790.
19. Richter E., Engl J., Friesenegger S., Tricker A.R. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man. Chem Res Toxicol 2009, 22:1008-1017.
20. Rivenson A., Hoffmann D., Prokopczyk B., Amin S., Hecht S.S. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 1988, 48:6912-6917.
21. Saad A.A., O'Connor P.J., Mostafa M.H., Metwalli N.E., Cooper D.P., Margison G.P., et al. Bladder tumor contains higher N7-methylguanine levels in DNA than adjacent normal bladder epithelium. Cancer Epidemiol Biomarkers Prev 2006, 15:740-743.
22. Spiegelhalder B., Bartsch H. Tobacco-specific nitrosamines. Eur J Cancer Prev 1996, 5(Suppl. 1):33-38.
23. Strope S.A., Montie J.E. The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. J Urol 2008, 180:31-37.
24. Tricker A.R., Brown B.G., Doolittle D.J., Richter E. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung and effect of cigarette smoke exposure on in vivo metabolism to biological reactive intermediates. Adv Exp Med Biol 2001, 500:451-454.
25. Tulunay O.E., Hecht S.S., Carmella S.G., Zhang Y., Lemmonds C., Murphy S., et al. Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers. Cancer Epidemiol Biomarkers Prev 2005, 14:1283-1286.
26. Zeegers M.P., Tan F.E., Dorant E., van Den Brandt P.A. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000, 89:630-639.